NLS Pharmaceutics Berita Eulerpool

NLS Pharmaceutics Berita Saham

NLS Pharmaceutics diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini NLS Pharmaceutics kami rangkum di sini.

• 18 November ·

  Yahoo
  NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
• 5 November ·

  Yahoo
  NLS and Kadimastem stocks soar following merger agreement
• 5 November ·

  Yahoo
  NLS Pharmaceutics, Kadimastem enter definitive merger agreement
• 4 November ·

  Yahoo
  NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement
• 28 Oktober ·

  Yahoo
  NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
• 28 Oktober ·

  TipRanks
  NLS Pharmaceutics Achieves Nasdaq Compliance Milestone
• 28 Oktober ·

  Seeking Alpha
  NLS Pharmaceutics regains compliance with Nasdaq
• 28 Oktober ·

  TipRanks
  NLS Pharmaceutics regains full compliance with Nasdaq listing rules
• 23 Oktober ·

  TipRanks
  NLS Pharmaceutics files to sell 2.75M common shares for holders
• 22 Oktober ·

  TipRanks
  NLS Pharmaceutics Strikes Debt Forgiveness Deal